180 filings
8-K
PIRS
Pieris Pharmaceuticals Inc
9 May 24
Other Events
8:00am
8-K
PIRS
Pieris Pharmaceuticals Inc
18 Apr 24
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
4:21pm
8-K
PIRS
Pieris Pharmaceuticals Inc
27 Mar 24
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
8:00am
8-K
PIRS
Pieris Pharmaceuticals Inc
21 Dec 23
Termination of a Material Definitive Agreement
4:30pm
8-K/A
PIRS
Pieris Pharmaceuticals Inc
31 Aug 23
Cost Associated with Exit or Disposal Activities
4:15pm
8-K
k5uq 2du5du
18 Jul 23
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
9:15am
8-K
vmyoeob
13 Jul 23
Departure of Directors or Certain Officers
12:00am
8-K
ui4tb
26 Jun 23
Departure of Directors or Certain Officers
5:25pm
8-K
n0s0r5e fp2urpky7y1
21 Jun 23
Results of Operations and Financial Condition
7:00am
8-K
3yx13cljztyu0539guw6
8 Jun 23
Regulation FD Disclosure
6:01am
8-K
c04meej hkx58
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
eshrmiw
10 May 23
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
7:30am
8-K
xvvmramcb361
29 Mar 23
Pieris Pharmaceuticals Reports Full-year 2022 Financial Results and Business Updates
7:30am
8-K
irfvc
10 Jan 23
Regulation FD Disclosure
4:31pm
8-K
kf5pk
4 Nov 22
Entry into a Material Definitive Agreement
4:30pm
8-K
5xvb5j8hbtpls717go2r
2 Nov 22
Pieris Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:43am
8-K
e8ahsw
1 Nov 22
Pieris Pharmaceuticals Announces Dosing of First Subject In Phase 1 Trial of Inhaled CTGF Inhibitor PRS-220
9:20am
8-K
jydlof8
13 Sep 22
PIERIS PHARMACEUTICALS SUPERIOR MEDICINES THROUGH EFFICIENT BIOLOGY CORPORATE PRESENTATION September 2022
8:23am
8-K
yjbjn1m722 6lc
4 Aug 22
Departure of Directors or Certain Officers
8:47am
8-K
y8mrvky4ghk m6zgtqu
4 Aug 22
Pieris Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:15am